Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pulmostem by Amniotics for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
Pulmostem is under clinical development by Amniotics and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections. According to...
Data Insights
Pulmostem by Amniotics for Influenzavirus A Infections: Likelihood of Approval
Pulmostem is under clinical development by Amniotics and currently in Phase II for Influenzavirus A Infections. According to GlobalData, Phase...